Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy-Reference-Cited by-同舟云学术

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

Published:2019-05-18 Issue:10 Volume:79 Page:1079-1089
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Wu Xiaoning¹,Scott Helen¹²,Carlsson Sigrid V.³⁴⁵,Sjoberg Daniel D.³,Cerundolo Lucia²,Lilja Hans²⁶⁷,Prevo Remko¹,Rieunier Guillaume⁸,Macaulay Valentine⁸,Higgins Geoffrey S.¹,Verrill Clare L.²⁹,Lamb Alastair D.²,Cunliffe Vincent T.¹⁰,Bountra Chas¹¹,Hamdy Freddie C.²,Bryant Richard J.¹²^ORCID

Affiliation:

1. Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology University of Oxford Oxford United Kingdom

2. Nuffield Department of Surgical Sciences University of Oxford Oxford United Kingdom

3. Department of Epidemiology & Biostatistics Memorial Sloan Kettering Cancer Center New York New York

4. Urology Service at the Department of Surgery Memorial Sloan Kettering Cancer Center New York New York

5. Department of Urology Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University Gothenburg Sweden

6. Department of Laboratory Medicine, Surgery (Urology), and Medicine (GU‐Oncology) Memorial Sloan Kettering Cancer Center New York New York

7. Department of Translational Medicine Lund University Malmö Sweden

8. Department of Oncology University of Oxford Oxford United Kingdom

9. Oxford NIHR Biomedical Research Centre University of Oxford Oxford United Kingdom

10. Department of Biomedical Science University of Sheffield Sheffield United Kingdom

11. Nuffield Department of Medicine, Structural Genomics Consortium University of Oxford Oxford United Kingdom

Funder

Cancerfonden

Breast Cancer Now

Institut National de la Santé et de la Recherche Médicale

Cancer Research UK

Prostate Cancer Foundation

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23817

Reference57 articles.

1. Cancer statistics, 2018

2. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

3. Cancer treatment and survivorship statistics, 2014

4. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

5. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets;Annals of Surgical Oncology;2024-05-17

2. Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post‐radiotherapy, and those with de novo metastatic disease;The Prostate;2024-04-23

3. MiR‐600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity;Journal of Biochemical and Molecular Toxicology;2023-12-21

4. Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those withde novometastatic disease;2023-09-06

5. Recent advances in EZH2-based dual inhibitors in the treatment of cancers;European Journal of Medicinal Chemistry;2023-08